Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at Radium 223 for men with prostate cancer that has spread to the bones (ALSYMPCA)

Overview

Cancer types:

Prostate cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at combining radium 223 (Xofigo) with best standard care to treat men whose prostate cancer had spread to their bones. This trial recruited men whose cancer was no longer responding to hormone therapy.

Recruitment start: 12 June 2008

Recruitment end: 1 February 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Christopher Parker

Supported by

Algeta ASA

Bayer Healthcare

Last reviewed: 13 January 2016

CRUK internal database number: 4969

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.